☰

Rachel J. Eclov - Publications

Affiliations: 
2013 Pharmaceutical Sciences and Pharmacogenomics University of California, San Francisco, San Francisco, CA 
Tree Info Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Eclov RJ, Kim MJ, Smith RP, Ahituv N, Kroetz DL. Rare Variants in the ABCG2 Promoter Modulate In Vivo Activity. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 29467213 DOI: 10.1124/Dmd.117.079541  0.589
2017 Eclov RJ, Kim MJ, Chhibber A, Smith RP, Ahituv N, Kroetz DL. ABCG2 regulatory single-nucleotide polymorphisms alter in-vivo enhancer activity and expression. Pharmacogenetics and Genomics. PMID 28930109 DOI: 10.1097/Fpc.0000000000000312  0.538
2016 Eclov RJ, Kim MJ, Smith RP, Liang X, Ahituv N, Kroetz DL. In Vivo Hepatic Enhancer Elements in the Human ABCG2 Locus. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 27856528 DOI: 10.1124/Dmd.116.072033  0.558
2012 Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, et al. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5099-109. PMID 22843789 DOI: 10.1158/1078-0432.Ccr-12-1590  0.519
Show low-probability matches.